EUVIMEDEUVIMED entdecken
Crossref

On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange

Vijay Alexander, Gayathiri Kaduvetti Chellaiya, S Gnanadeepam, Vinoi George David, Ebor James, Subramani Kandasamy, Kundavaram Paul Prabhakar Abhilash, Santosh Varughese, Sukesh Chandran Nair, Sandeep Kumar, P Krishna Bharadwaj, S Akilesh und 6 weitere

Indian Journal of Gastroenterology · 2024

DOI: 10.1007/s12664-024-01585-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Gastroenterology, 2024. Verfasst von Vijay Alexander und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Christian Medical College, Vellore, 632 004, India. Hauptthemen laut MEDLINE: Plasma Exchange, Liver Transplantation, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Plasma exchange (PLEX) improves survival in patients with rodenticidal hepatotoxicity. However, predictors of treatment response are unknown. We aimed at assessing predictors of response to PLEX treatment in these patients. METHODS: Patients with rodenticidal hepatotoxicity from 2014 to 2023 managed in our department were included in this study. Kochi criteria (model for end-stage liver disease [MELD] score ≥ 36 or international normalized ratio [INR] ≥ 6 with hepatic encephalopathy [HE]) derived specifically for rodenticidal hepatotoxicity (PubMed IDentifier [PMID]: 26310868) were used to assess need for liver transplantation. We analyzed predictors of survival at one month. ∆Bilirubin, ∆MELD score and ∆INR were calculated as percentage change of the parameter after third PLEX session (or after last PLEX if < 3 PLEX sessions done) from baseline pre-PLEX value. RESULTS: Of 200 patients with rodenticidal hepatotoxicity, 114 patients were treated with low-volume PLEX (PLEX-LV). No patient had liver transplantation. Of 78 patients who fulfilled Kochi criteria, 32 patients were PLEX-LV eligible and underwent PLEX-LV (M: 10; age: 20.5, 7-70 years; median, range; acute liver failure: 24). Twenty-two (69%; acute liver failure: 14) of the 32 patients were alive at one month. Presence of HE (p = 0.03) and ∆MELD (p < 0.001) were significant predictors on univariate analysis, while ∆MELD (aOR = 0.88, 95% CI: 0.79-0.98, p = 0.01) was the only significant independent predictor of one-month transplant-free survival. Area under receiver operating characteristic (ROC) for ∆MELD was 0.93 (95% CI:0.85-1.00) and a decrease of ≥ 20% in MELD score while on PLEX-LV had 90% sensitivity and 90% specificity in predicting one-month survival. CONCLUSIONS: Decline in MELD while on PLEX-LV independently predicted one-month transplant-free survival in rodenticidal hepatotoxicity patients. This may help guide decision on stopping PLEX-LV in patients predicted to respond to treatment and to consider alternate treatment options in non-responders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangeLiver TransplantationChemical and Drug Induced Liver InjuryHumansMaleAdultFemaleMiddle AgedYoung AdultAdolescentAgedChildTreatment OutcomeEnd Stage Liver DiseaseSeverity of Illness IndexPredictive Value of TestsTime FactorsRetrospective Studies

Stichwörter der Autor:innen

Acute liver failureKochi criteriaLiver transplantationLow-volume plasma exchangePhosphorusRodenticidal hepatotoxicityTransplant-free survival

Autor:innen und Institutionen

  • Department of Hepatology, Christian Medical College, Vellore, 632 004, India.
  • Transfusion Medicine and Immunohematology, Christian Medical College, Vellore, 632 004, India.
  • Nursing Services, Christian Medical College, Vellore, 632 004, India.
  • Department of Nephrology, Christian Medical College, Vellore, 632 004, India.
  • Pediatric Intensive Care Unit, Christian Medical College, Vellore, 632 004, India.
  • Division of Critical Care, Christian Medical College, Vellore, 632 004, India.

ORCID-Profile: Ashish Goel

Zitieren

APA

Alexander, V., Chellaiya, G. K., Gnanadeepam, S., David, V. G., James, E., Kandasamy, S., Abhilash, K. P. P., Varughese, S., Nair, S. C., Kumar, S., Bharadwaj, P. K., Akilesh, S., Kumar, S. E., Daniel, D., Jayaraman, S., Zachariah, U., Eapen, C. E., & Goel, A. (2024). On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange. Indian Journal of Gastroenterology. https://doi.org/10.1007/s12664-024-01585-3

Vancouver

Alexander V, Chellaiya GK, Gnanadeepam S, David VG, James E, Kandasamy S, et al. On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange. Indian Journal of Gastroenterology. 2024. doi:10.1007/s12664-024-01585-3

BibTeX
@article{Alexander2024,
  author = {Alexander, Vijay and Chellaiya, Gayathiri Kaduvetti and Gnanadeepam, S and David, Vinoi George and James, Ebor and Kandasamy, Subramani and Abhilash, Kundavaram Paul Prabhakar and Varughese, Santosh and Nair, Sukesh Chandran and Kumar, Sandeep and Bharadwaj, P Krishna and Akilesh, S and Kumar, Santhosh E and Daniel, Dolly and Jayaraman, Sumathy and Zachariah, Uday and Eapen, Chundamannil E and Goel, Ashish},
  title = {On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange},
  journal = {Indian Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s12664-024-01585-3}
}
Kostenlos starten →